Rheumatism: Etiology, Pathology and Treatment

Dear Colleagues,

The term rheumatism was used in historical contexts to refer to rheumatic diseases, including all forms of arthritis and spondyloarthropathies characterized by chronic inflammation affecting the joints, muscles, and bones.

The pathogenesis of rheumatic diseases (RDs) involves a complex network of many type of immune cells, genes modification, and environmental factors. Moreover, the inflammation associated with rheumatic diseases can damage other organ systems resulting in their insufficiency and development of comorbidities.

Rheumatic diseases can be described as conditions characterized by persistent pain and a progressive course, finally resulting in a worsening quality of life. The increased knowledge of the pathogenesis of rheumatic diseases can result in the improvement of diagnosis and therapeutic options characterized by a multi-disciplinary approach, depending on the disease course and individual symptoms. Different types of medication, techniques of surgery, and kinds of rehabilitation are used for the treatment of rheumatic diseases. Among the drugs, some can limit the pain and inflammation, while others can modify the course of the disease.

This Special Issue is dedicated to all aspects of rheumatic diseases, modern therapies used in rheumatology, and future possible drug combinations. Considering the above, in this Special Issue, we aim to publish manuscripts focusing on the exploration of diagnosis, pathogenesis, and treatment in rheumatic diseases.

The topic include, but are not limited to, the following;

• Rheumatic diseases;
• Molecular and genetic mechanism in pathogenesis of RDs;
• Diagnosis and treatment in the whole range;
• Complications and comorbidities.

Prof. Dr. Marzena Helena Olesińska
Prof. Dr. Barbara Lisowska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• rheumatic disease
• pathogenesis
• diagnosis
• treatment